Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 03 05 2023
accepted: 22 08 2023
medline: 22 9 2023
pubmed: 20 9 2023
entrez: 20 9 2023
Statut: epublish

Résumé

Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends on therapeutic antibodies or small-molecule drugs in cases of severe disease. However, perpetual viral evolution has required continuous efficacy monitoring as well as exploration of new therapeutic antibodies, to circumvent resistance mutations arising in the viral population. We performed SARS-CoV-2-specific B cell sorting and subsequent single-cell sequencing on material from 15 SARS-CoV-2 convalescent participants. Through screening of 455 monoclonal antibodies for SARS-CoV-2 variant binding and virus neutralization, we identified a cluster of activated B cells highly enriched for SARS-CoV-2 neutralizing antibodies. Epitope binning and Cryo-EM structure analysis identified the majority of neutralizing antibodies having epitopes overlapping with the ACE2 receptor binding motif (class 1 binders). Extensive functional antibody characterization identified two potent neutralizing antibodies, one retaining SARS-CoV-1 neutralizing capability, while both bind major common variants of concern and display prophylactic efficacy in vivo. The transcriptomic signature of activated B cells harboring broadly binding neutralizing antibodies with therapeutic potential identified here, may be a guide in future efforts of rapid therapeutic antibody discovery.

Identifiants

pubmed: 37729215
doi: 10.1371/journal.pone.0291131
pii: PONE-D-23-12939
pmc: PMC10511142
doi:

Substances chimiques

COVID-19 Vaccines 0
Blood Group Antigens 0
Antibodies, Viral 0
Antibodies, Neutralizing 0
Epitopes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0291131

Informations de copyright

Copyright: © 2023 Lende et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Immunity. 2022 Jun 14;55(6):1105-1117.e4
pubmed: 35397794
Nature. 2022 Feb;602(7898):657-663
pubmed: 35016194
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Science. 2020 Aug 28;369(6507):1119-1123
pubmed: 32661058
Cell. 2019 Dec 12;179(7):1636-1646.e15
pubmed: 31787378
MMWR Morb Mortal Wkly Rep. 2022 Jan 07;71(1):19-25
pubmed: 34990440
EBioMedicine. 2021 Feb;64:103230
pubmed: 33530000
Cell. 2020 Jul 9;182(1):73-84.e16
pubmed: 32425270
Cell. 2021 Jun 10;184(12):3086-3108
pubmed: 34087172
Lancet Infect Dis. 2022 Nov;22(11):e311-e326
pubmed: 35803289
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
Cell Rep. 2020 Jan 21;30(3):905-913.e6
pubmed: 31968262
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
JAMA. 2022 Apr 5;327(13):1236-1246
pubmed: 35285853
Nat Rev Immunol. 2022 Jan;22(1):7-18
pubmed: 34873279
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
J Immunol. 2016 Aug 15;197(4):1159-68
pubmed: 27357154
N Engl J Med. 2021 Jan 21;384(3):229-237
pubmed: 33113295
PLoS Comput Biol. 2016 Jan 11;12(1):e1004409
pubmed: 26751373
Clin Microbiol Infect. 2022 Aug;28(8):1126-1133
pubmed: 35283313
PLoS One. 2013 May 22;8(5):e63906
pubmed: 23717507
Clin Infect Dis. 2021 Dec 6;73(11):2065-2072
pubmed: 33906236
J Immunother Cancer. 2021 Jun;9(6):
pubmed: 34117116
Microb Cell Fact. 2021 Apr 22;20(1):88
pubmed: 33888152
J Exp Med. 2013 Mar 11;210(3):457-64
pubmed: 23420879
Nat Methods. 2019 Dec;16(12):1289-1296
pubmed: 31740819
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2567-75
pubmed: 24821781
EMBO J. 2006 Feb 22;25(4):889-99
pubmed: 16456548
Nature. 2021 Sep;597(7874):97-102
pubmed: 34261126
Cell. 2021 Jun 24;184(13):3573-3587.e29
pubmed: 34062119
Signal Transduct Target Ther. 2021 May 17;6(1):195
pubmed: 34001847
Trends Immunol. 2022 Mar;43(3):210-229
pubmed: 35090788
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):531-544
pubmed: 29872004
Nat Immunol. 2020 Dec;21(12):1506-1516
pubmed: 33028979
N Engl J Med. 2021 Dec 2;385(23):e81
pubmed: 34587383
Front Immunol. 2020 Feb 25;11:32
pubmed: 32158442
N Engl J Med. 2021 Nov 18;385(21):1941-1950
pubmed: 34706189
Front Immunol. 2022 Jan 27;13:829665
pubmed: 35154152
Nat Microbiol. 2021 Sep;6(9):1140-1149
pubmed: 34290390
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Methods Mol Biol. 2015;1266:171-84
pubmed: 25560075
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
BMJ. 2022 Mar 2;376:e068632
pubmed: 35236664
EBioMedicine. 2021 Jun;68:103410
pubmed: 34098342
Science. 2021 Oct 22;374(6566):472-478
pubmed: 34554826
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Cell Rep. 2019 Apr 30;27(5):1446-1460.e4
pubmed: 31042472
J Mol Biol. 2006 May 5;358(3):764-72
pubmed: 16563430
Cell. 2021 Jun 10;184(12):3205-3221.e24
pubmed: 34015271
Front Med Technol. 2022 Mar 28;4:867982
pubmed: 35419561
Protein Sci. 2020 Apr;29(4):1069-1078
pubmed: 31730249
Int J Infect Dis. 2022 Jan;114:252-260
pubmed: 34800687
IUCrJ. 2019 Jun 27;6(Pt 4):526-531
pubmed: 31316797
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Nat Methods. 2020 Dec;17(12):1214-1221
pubmed: 33257830
Nature. 2020 Jun;582(7813):561-565
pubmed: 32365353
Cell. 2021 Apr 1;184(7):1858-1864.e10
pubmed: 33631096
Front Immunol. 2019 Oct 18;10:2458
pubmed: 31681331
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
N Engl J Med. 2021 Oct 7;385(15):1382-1392
pubmed: 34260849
Cell. 2020 Nov 12;183(4):1024-1042.e21
pubmed: 32991844
Nat Methods. 2019 Nov;16(11):1146-1152
pubmed: 31591575
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nature. 2021 Jul;595(7867):426-431
pubmed: 34126625
Vaccines (Basel). 2022 Apr 28;10(5):
pubmed: 35632450
Immunity. 2016 Jan 19;44(1):116-130
pubmed: 26795247
Ann Rheum Dis. 2022 Jul;81(7):1023-1027
pubmed: 34819271
J Exp Med. 1991 Jun 1;173(6):1297-304
pubmed: 1709674
Nature. 2021 Jul;595(7867):421-425
pubmed: 34030176
Biochem Biophys Res Commun. 2012 Oct 12;427(1):202-6
pubmed: 22995298
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
J Exp Med. 2002 Jul 1;196(1):65-75
pubmed: 12093871
Nature. 2022 Jul;607(7917):128-134
pubmed: 35447027

Auteurs

Stine Sofie Frank Lende (SSF)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Randi Westh Hansen (RW)

Symphogen, Ballerup, Denmark.

Harsh Bansia (H)

Structural Biology Initiative, CUNY Advanced Science Research Center, New York, NY, United States of America.

Mike Vestergaard (M)

Symphogen, Ballerup, Denmark.

Frederik Holm Rothemejer (FH)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Anne Worsaae (A)

Symphogen, Ballerup, Denmark.

Deijona Brown (D)

Structural Biology Initiative, CUNY Advanced Science Research Center, New York, NY, United States of America.

Maria Lange Pedersen (ML)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Anna Halling Folkmar Rahimic (AHF)

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Anna Karina Juhl (AK)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark.

Torben Gjetting (T)

Structural Biology Initiative, CUNY Advanced Science Research Center, New York, NY, United States of America.
Antibody Technology, Novo Nordisk A/S, Måløv, Denmark.

Lars Østergaard (L)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Amédée Des Georges (AD)

Structural Biology Initiative, CUNY Advanced Science Research Center, New York, NY, United States of America.
Department of Chemistry and Biochemistry, City College of New York, New York, NY, United States of America.
PhD Programs in Biochemistry, and Chemistry, Graduate Center, City University of New York, New York, NY, United States of America.

Laurent-Michel Vuillard (LM)

Servier, Suresnes, France.

Mariane Høgsbjerg Schleimann (MH)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark.

Klaus Koefoed (K)

Symphogen, Ballerup, Denmark.

Martin Tolstrup (M)

Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH